Table 1 Demographic and clinical characteristic of cervical cancer patients according to HIV status, TASH, Addis Ababa, Ethiopia, 2008–2012
Patient demographic characteristics | HIV status | ||
|---|---|---|---|
HIV negative n (%) | HIV positive n (%) | HIV unknown n (%) | |
Residence | |||
Urban | 128 (34.4) | 82 (59) | 431 (37.7) |
Rural | 244 (65.6) | 57 (41) | 713 (62.3) |
Marital status | |||
Single | 3 (0.8) | 5 (3.6) | 4 (0.4) |
Married | 297 (79.8) | 113 (81.3) | 928 (81.1) |
Unknown | 72 (19.4) | 21 (15.1) | 212 (18.5) |
Age category | |||
< 30 | 15 (4.0) | 29 (20.9) | 47 (4.1) |
30–39 | 81 (21.8) | 58 (41.7) | 243 (21.2) |
40–49 | 131 (35.2) | 40 (28.8) | 389 (34) |
50–59 | 88 (23.7) | 10 (7.2) | 295 (25.8) |
60+ | 57 (15.3) | 2 (1.4) | 170 (14.9) |
FIGO stage at presentation | |||
I-IIA | 59 (15.8) | 10 (7.2) | 95 (8.3) |
IIB-IIIA | 148 (39.8) | 57 (41.0) | 51 (45.1) |
IIIB-IVA | 144 (38.7) | 62 (44.6) | 458 (40.0) |
IVB | 6 (1.6) | 5 (3.6) | 15 (1.3) |
Post-operative | 7 (1.9) | 2 (1.4) | 23 (2.0) |
Recurrence | 7 (1.9) | 3 (2.2) | 28 (2.5) |
Unknown | 1 (0.3) | 0 | 9 (0.8) |
Anemia Status | |||
No anemia ≥12 | 186 (50) | 51 (36.7) | 437 (38.2) |
> 10 and <12 | 93 (25) | 38 (27.3) | 373 (32.6) |
8–10 | 36 (9.7) | 24 (17.3) | 153 (13.4) |
> 5 and <8 | 24 (6.5) | 12 (8.6) | 73 (6.4) |
< 5 | 15 (4.0) | 12 (8.6) | 60 (5.2) |
Unknown | 18 (4.9) | 2 (1.4) | 48(4.2) |
Co-morbidity status | |||
No co morbidity | 341 (91.7) | 124 (89.2) | 1045(91.3) |
Any co morbidity | 31 (8.3) | 15 (10.8) | 99 (8.7) |
Treatment modalities | |||
Radiation | 187 (63.8) | 105 (79.5) | 789 (75.0) |
Surgery | 71 (24.2) | 12 (9.0) | 107 (10.0) |
Chemotherapy | 35 (12.0) | 15 (11.5) | 156 (15.0) |
Patient outcome | |||
Alive | 331 (89.0) | 108 (77.7) | 930 (81.3) |
Dead | 41 (11.0) | 31 (22.3) | 214 (18.7) |
Total | 372 | 139 | 1144 |